PTGS2 and prostate carcinoma: Further studies in other prostate cancer cells, ideally with different basal levels of the synthetic and degradative enzymes and with other inflammatory mediators, are warranted in order to shed more light upon the relationship between inflammation and the disturbed eCB system in prostate cancer and the functional consequence of increased COX-2 levels upon the levels and metabolism of AEA.